doi: 10.1016/s0014-5793(99)01762-7.
Mildly oxidised low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin
Affiliations
- PMID: 10648815
- DOI: 10.1016/s0014-5793(99)01762-7
Item in Clipboard
Mildly oxidised low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin
FEBS Lett.
.
Free article
Abstract
Oxidised low density lipoprotein (LDL) plays an important role in the pathogenesis of atherosclerosis. Here we demonstrate that mildly oxidised (mox) LDL engages the GTPase Rho and its effector molecule p160 Rho-kinase to induce phosphorylation of myosin light chain and of moesin leading to platelet shape change. Pretreatment of platelets with the selective Rho inhibitor C3-transferase from Clostridium botulinum or with the Rho-kinase inhibitor Y-27632 blocked mox-LDL-induced myosin light chain phosphorylation, moesin phosphorylation and shape change. Mox-LDL did not induce an increase in cytosolic Ca(2+) during shape change. We propose that Rho/Rho-kinase inhibition could be a strategy for prevention of the pathologic platelet activation during atherogenesis.
Similar articles
-
Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation.Cell Signal. 2000 Oct;12(9-10):645-8. doi: 10.1016/s0898-6568(00)00108-x. Cell Signal. 2000. PMID: 11080616
-
Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase.J Biol Chem. 1999 Oct 22;274(43):30361-4. doi: 10.1074/jbc.274.43.30361. J Biol Chem. 1999. PMID: 10521411
-
Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.J Biol Chem. 1999 Oct 1;274(40):28293-300. doi: 10.1074/jbc.274.40.28293. J Biol Chem. 1999. PMID: 10497186
-
[Involvement of small GTPase Rho and Rho-kinase in the pathogenesis of hypertension and hypertensive target organ damage].Nihon Rinsho. 2004 Mar;62 Suppl 3:202-6. Nihon Rinsho. 2004. PMID: 15171369 Review. Japanese. No abstract available.
-
Activation of moesin and adducin by Rho-kinase downstream of Rho.Biophys Chem. 1999 Dec 13;82(2-3):139-47. doi: 10.1016/s0301-4622(99)00113-1. Biophys Chem. 1999. PMID: 10631797 Review.
Cited by
-
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications.Sci Rep. 2018 Jan 11;8(1):498. doi: 10.1038/s41598-017-18985-5. Sci Rep. 2018. PMID: 29323256 Free PMC article.
-
A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.Circ Res. 2008 Jun 20;102(12):1512-9. doi: 10.1161/CIRCRESAHA.108.172064. Epub 2008 May 22. Circ Res. 2008. PMID: 18497330 Free PMC article.
-
Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.Blood. 2013 Jul 25;122(4):580-9. doi: 10.1182/blood-2013-04-491688. Epub 2013 May 22. Blood. 2013. PMID: 23699602 Free PMC article.
-
Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.Heart Vessels. 2008 Jul;23(4):249-56. doi: 10.1007/s00380-008-1038-9. Epub 2008 Jul 23. Heart Vessels. 2008. PMID: 18649055 Clinical Trial.
-
Roles of lysophosphatidic acid in cardiovascular physiology and disease.Biochim Biophys Acta. 2008 Sep;1781(9):563-70. doi: 10.1016/j.bbalip.2008.05.008. Epub 2008 Jun 10. Biochim Biophys Acta. 2008. PMID: 18586114 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
